COVID-19

Outside of the loss of human life due to the COVID-19 pandemic, the past two years have greatly affected hospitals, health systems and the way providers deliver care. Healthcare executives are grappling with federal monetary assistance, growing burnout rates, workforce shortages and federal oversight of vaccines and testing. This channel is also designed to update clinicians on new research and guidelines regarding COVID patient treatment strategies and risk assessments.

RSS icon
Thumbnail

COVID-19 could cost US hospitals $323B in 2020 alone

The report comes as confirmed cases continue to rise in certain parts of the country. If that surge continues, the pandemic's financial impact “could be even more significant.”

Thumbnail

Study shows COVID-19 can infect heart cells—and do serious damage in the process

COVID-19 has the potential to infect cardiac cells, causing changes in their ability to function after just 72 hours. 

Thumbnail

STEMI care in the wake of COVID-19: 3 research teams share their findings

COVID-19 has disrupted routine cardiovascular care all over the world, with some procedures getting delayed for months and many hospitals reporting a significant drop in myocardial infarction patients.

covid-19 coronavirus

Statin use leads to lower death rates among COVID-19 patients

The study included data from nearly 14,000 COVID-19 patients.

Thumbnail

What cardiologists should know about MIPS participation and COVID-19

Cardiologists participating in MIPS in 2020 didn’t exactly plan on providing care during a global pandemic.

Thumbnail

A fresh look at what does (age, diabetes) and does not (hypertension) predict death from COVID-19

A new analysis explored if age, numerous comorbidities, the use of CVD medication and Charleston Comorbidity Index scores can be used to predict mortality among confirmed COVID-19 patients. 

Thumbnail

Cardiologists shed new light on COVID-19 and cardiac arrhythmias

A higher rate of cardiac arrhythmias has been observed in hospitalized COVID-19 patients, but new research suggests there’s more behind that trend than the virus itself.

Thumbnail

Dexamethasone improves outcomes for critically ill COVID-19 patients

Why dexamethasone could be a legitimate game-changer in the fight against COVID-19—and an update on the FDA and hydroxychloroquine.

Displaying 345 - 352 of 427

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.